BRCA2 and neuroblastoma: BRCA2 is tightly correlated with a proliferation gene signature in neuroblastoma across the SEQC, Primary NRC, and TARGET datasets (Pearson R = 0.894, 0.870, and 0.876, respectively; Figure 4E), perhaps explaining the association with these measures of aggressive disease.